Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Gains 7%; BSE HEALTHCARE Index Up 0.6%
Wed, 24 Jul 11:21

ALEMBIC PHARMA Gains 7%; BSE HEALTHCARE Index Up 0.6%Image source: Chunumunu/www.istockphoto.com

ALEMBIC PHARMA share price has zoomed 7% and is presently trading at Rs 1,160.3.

Meanwhile, the BSE HEALTHCARE index is at 38,964.4 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 4.2%) and Sanofi India (up 2.6%).

Torrent Pharma (down 3.0%) and ASTRAZENECA PHARMA (down 2.3%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 685.8 to Rs 1,160.3, registering a gain of Rs 474.6 (up 69.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 38,964.4, registering a gain of 45.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 96.2%), Jubilant Pharmova (up 95.7%) and Lupin (up 93.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,207.9 (down 0.3%).

The top losers among the BSE Sensex today are Bajaj Finance (down 2.6%) and Bajaj Finserv (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,441.4 (down 0.2%). Tata Consumer Products and Bajaj Finance are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,207.9, registering a gain of 13,823.1 points (up 20.8%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 10.9% YoY to Rs 1,786 million for the quarter ended March 2024, compared to a profit of Rs 1,611 million a year ago. Net sales rose 7.9% to Rs 15,170 million during the period as against Rs 14,065 million in January-March 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 37.0.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Gains 7%; BSE HEALTHCARE Index Up 0.6%". Click here!